what strategies did Roche pharmaceuticals use to acquire Genentech? I know that one of them involved the sale of 16% of Genentech stock back to the public in an IPO in June of 1999, but I'm wondering about other strategies. From what I understand, Roche's process of acquiring Genentech was gradual, beginning with collaborations between the two companies.